Figure 2From: A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus- a randomized controlled trial START-J studyPlasma glucose and insulin curves under 75 g-OGTT at baseline and three months. Plasma glucose (A) and serum insulin (B) under 75-gram oral glucose tolerance test (75 g-OGTT) at baseline (A and B, respectively) and 3 months after treatment (C and D, respectively). Data are mean ± SEM of 9 patients of the control group and 12 patients of the sitagliptin group.Back to article page